Desferioximine induced Ototoxicity in Thalassemic patients

BACKGROUND: Thalassemia is a hereditary disorder requiring regular blood transfusion. PURPOSE: To determine hearing sensitivity in transfusion-dependent thalassemics who were receiving desferioximine and on oral iron chelation (desferioximine) therapy. METHODS: 26 patients with B-thelassemia in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Vir, Dharam, Panda, N. K., Marwaha, R. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Indian Academy of Neurosciences 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117009/
https://www.ncbi.nlm.nih.gov/pubmed/25205902
http://dx.doi.org/10.5214/ans.0972.7531.1017407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117009/
https://www.ncbi.nlm.nih.gov/pubmed/25205902
http://dx.doi.org/10.5214/ans.0972.7531.1017407

Ejemplares similares